Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers

Published:2017-09-27 Issue:1 Volume:17 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Deluche Elise,Venat-Bouvet Laurence,Leobon Sophie,Fermeaux Veronique,Mollard Joelle,Saidi Nadira,Jammet Isabelle,Aubard Yves,Tubiana-Mathieu Nicole

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-017-3648-z.pdf

Reference30 articles.

1. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thürlimann B, Senn H-J, et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol. 2007;18:1133–44.

2. Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013. Ann Oncol. 2013;24:2206–23.

3. Ignatiadis M, Sotiriou C. Understanding the molecular basis of histologic grade. Pathobiology. 2008;75:104–11.

4. Aleskandarany MA, Rakha EA, Macmillan RD, Powe DG, Ellis IO, Green AR. MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups. Breast Cancer Res Treat. 2011;127:591–9.

5. Buta M, Džodić R, \DJurišić I, Marković I, Vujasinović T, Markićević M, et al. potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up. Tumor Biol. 2015;36:8193–200.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry;The Breast;2022-08

2. Breast Cancer 18F-ISO-1 Uptake as a Marker of Proliferation Status;Journal of Nuclear Medicine;2019-12-13

3. Levels of uPA and PAI-1 in breast cancer and its correlation to Ki67-index and results of a 21-multigene-array;Diagnostic Pathology;2018-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3